BioSig Technologies, Inc. intends to offer shares of common stock (or pre-funded warrants) through a public offering to purchase gold bullion and for general corporate purposes.
Clear Street and Needham & Company are joint book-running managers of the offering.
The offering is made pursuant to a shelf registration statement on Form S-3 declared effective by the SEC.
Public Offering Announcement
BioSig Technologies, Inc. is offering shares of common stock (or pre-funded warrants) for investment in gold bullion and corporate purposes.
Book-Running Managers
Clear Street and Needham & Company are acting as joint book-running managers for the offering.
SEC Registration Statement
The offering is being conducted under a shelf registration statement on Form S-3 declared effective by the SEC.
- The offering signals BioSig Technologies, Inc.'s strategic move to raise capital for investment purposes.
- With Clear Street and Needham & Company as book-running managers, the offering is expected to attract investor interest.
- The successful completion of the offering will provide BioSig Technologies, Inc. with funds for gold investments and operational needs.
BioSig Technologies, Inc.'s public offering announcement reflects its focus on strategic investments and operational growth through capital raising.